161 related articles for article (PubMed ID: 37573347)
1. Deubiquitinase YOD1 suppresses tumor progression by stabilizing E3 ligase TRIM33 in head and neck squamous cell carcinoma.
Wu Y; Duan Y; Han W; Cao J; Ye B; Chen P; Li H; Wang Y; Liu J; Fang Y; Yue K; Wu Y; Wang X; Jing C
Cell Death Dis; 2023 Aug; 14(8):517. PubMed ID: 37573347
[TBL] [Abstract][Full Text] [Related]
2. Blockade of deubiquitinating enzyme PSMD14 overcomes chemoresistance in head and neck squamous cell carcinoma by antagonizing E2F1/Akt/SOX2-mediated stemness.
Jing C; Duan Y; Zhou M; Yue K; Zhuo S; Li X; Liu D; Ye B; Lai Q; Li L; Yao X; Wei H; Zhang W; Wu Y; Wang X
Theranostics; 2021; 11(6):2655-2669. PubMed ID: 33456565
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the OTUB1-YAP1 axis in driving malignant behaviors of head and neck squamous cell carcinoma.
Jin S; Tsunematsu T; Horiguchi T; Mouri Y; Shao W; Miyoshi K; Hagita H; Sarubo M; Fujiwara N; Qi G; Ishimaru N; Kudo Y
Cancer Med; 2023 Dec; 12(24):22156-22169. PubMed ID: 37986681
[TBL] [Abstract][Full Text] [Related]
4. Deubiquitinase YOD1 potentiates YAP/TAZ activities through enhancing ITCH stability.
Kim Y; Kim W; Song Y; Kim JR; Cho K; Moon H; Ro SW; Seo E; Ryu YM; Myung SJ; Jho EH
Proc Natl Acad Sci U S A; 2017 May; 114(18):4691-4696. PubMed ID: 28416659
[TBL] [Abstract][Full Text] [Related]
5. The deubiquitinase USP7 promotes HNSCC progression via deubiquitinating and stabilizing TAZ.
Li J; Dai Y; Ge H; Guo S; Zhang W; Wang Y; Liu L; Cheng J; Jiang H
Cell Death Dis; 2022 Aug; 13(8):677. PubMed ID: 35931679
[TBL] [Abstract][Full Text] [Related]
6. E3 Ubiquitin Ligase RNF125 Suppresses Immune Escape in Head and Neck Squamous Cell Carcinoma by Regulating PD-L1 Expression.
Jiang C; He L; Xiao S; Wu W; Zhao Q; Liu F
Mol Biotechnol; 2023 Jun; 65(6):891-903. PubMed ID: 36344734
[TBL] [Abstract][Full Text] [Related]
7. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
[TBL] [Abstract][Full Text] [Related]
8. YOD1 attenuates neurogenic proteotoxicity through its deubiquitinating activity.
Tanji K; Mori F; Miki Y; Utsumi J; Sasaki H; Kakita A; Takahashi H; Wakabayashi K
Neurobiol Dis; 2018 Apr; 112():14-23. PubMed ID: 29330040
[TBL] [Abstract][Full Text] [Related]
9. UBE2C promotes the progression of head and neck squamous cell carcinoma.
Jin Z; Zhao X; Cui L; Xu X; Zhao Y; Younai F; Messadi D; Hu S
Biochem Biophys Res Commun; 2020 Mar; 523(2):389-397. PubMed ID: 31870550
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980
[TBL] [Abstract][Full Text] [Related]
11. A deubiquitinase negatively regulates retro-translocation of nonubiquitinated substrates.
Bernardi KM; Williams JM; Inoue T; Schultz A; Tsai B
Mol Biol Cell; 2013 Nov; 24(22):3545-56. PubMed ID: 24068323
[TBL] [Abstract][Full Text] [Related]
12. Deubiquitinase YOD1: the potent activator of YAP in hepatomegaly and liver cancer.
Kim Y; Jho EH
BMB Rep; 2017 Jun; 50(6):281-282. PubMed ID: 28502290
[TBL] [Abstract][Full Text] [Related]
13. Long non‑coding RNA MIR4435‑2HG promotes the progression of head and neck squamous cell carcinoma by regulating the miR‑383‑5p/RBM3 axis.
Wang S; Chen X; Qiao T
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846802
[TBL] [Abstract][Full Text] [Related]
14. PLEK2 promotes cancer stemness and tumorigenesis of head and neck squamous cell carcinoma via the c-Myc-mediated positive feedback loop.
Zhao X; Shu D; Sun W; Si S; Ran W; Guo B; Cui L
Cancer Commun (Lond); 2022 Oct; 42(10):987-1007. PubMed ID: 36002342
[TBL] [Abstract][Full Text] [Related]
15. LncRNA LINC00460 promotes EMT in head and neck squamous cell carcinoma by facilitating peroxiredoxin-1 into the nucleus.
Jiang Y; Cao W; Wu K; Qin X; Wang X; Li Y; Yu B; Zhang Z; Wang X; Yan M; Xu Q; Zhang J; Chen W
J Exp Clin Cancer Res; 2019 Aug; 38(1):365. PubMed ID: 31429766
[TBL] [Abstract][Full Text] [Related]
16. Carboxyl-Terminal Modulator Protein Positively Acts as an Oncogenic Driver in Head and Neck Squamous Cell Carcinoma via Regulating Akt phosphorylation.
Chang JW; Jung SN; Kim JH; Shim GA; Park HS; Liu L; Kim JM; Park J; Koo BS
Sci Rep; 2016 Jun; 6():28503. PubMed ID: 27328758
[TBL] [Abstract][Full Text] [Related]
17. A transcriptomic map of EGFR-induced epithelial-to-mesenchymal transition identifies prognostic and therapeutic targets for head and neck cancer.
Schinke H; Shi E; Lin Z; Quadt T; Kranz G; Zhou J; Wang H; Hess J; Heuer S; Belka C; Zitzelsberger H; Schumacher U; Genduso S; Riecken K; Gao Y; Wu Z; Reichel CA; Walz C; Canis M; Unger K; Baumeister P; Pan M; Gires O
Mol Cancer; 2022 Sep; 21(1):178. PubMed ID: 36076232
[TBL] [Abstract][Full Text] [Related]
18. CSC-3436 inhibits TWIST-induced epithelial-mesenchymal transition via the suppression of Twist/Bmi1/Akt pathway in head and neck squamous cell carcinoma.
Lai YJ; Yu WN; Kuo SC; Ho CT; Hung CM; Way TD; Chen CT
J Cell Physiol; 2019 Jun; 234(6):9118-9129. PubMed ID: 30341909
[TBL] [Abstract][Full Text] [Related]
19. HOXB5 acts as an oncogenic driver in head and neck squamous cell carcinoma via EGFR/Akt/Wnt/β-catenin signaling axis.
Lee K; Chang JW; Oh C; Liu L; Jung SN; Won HR; Kim YI; Rha KS; Koo BS
Eur J Surg Oncol; 2020 Jun; 46(6):1066-1073. PubMed ID: 31864826
[TBL] [Abstract][Full Text] [Related]
20. YOD1 Deubiquitinates NEDD4 Involved in the Hippo Signaling Pathway.
Park JH; Kim SY; Cho HJ; Lee SY; Baek KH
Cell Physiol Biochem; 2020 Jan; 54(1):1-14. PubMed ID: 31916733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
